QUEST NP NEEDS Assessment

Section 1: Background Information and Honorarium

First Name *

Last Name *

Mailing Address *

City *

Province *

Postal Code *

Please enter "na" for information not applicable

Corporation Name

GST/HST#

Other Tax rate (applicable if other than 13%)

Clinic Name:

Clinic Address:

City:

Postal Code:

Section 2: Management of Type 2 Diabetes in Primary Care

1) Approximately what percentage of your patients in your practice have T2D? *

<10%

10–20%

21–30%

>30%

2) Which of the following A1C targets aligns with current Diabetes Canada guidelines for most non-pregnant adults living with type 2 diabetes? *

< 6.0%

< 6.5%

< 7.0%

< 8.0%

3) Do you routinely screen for the following in your T2D patients? (Yes / No / Not Sure)

5) Which of the following clinical findings would most likely prompt screening for diabetic nephropathy in a patient with T2D? (Select the most appropriate option) *

Recurrent episodes of hypoglycemia

Persistent microalbuminuria on urine testing

Unexplained weight gain

Mild peripheral neuropathy

Dry skin and foot calluses

6) How do you typically stay informed about updates to clinical guidelines across various disease states? (SELECT TOP 3) *

Continuing Medical Education (CME) events (e.g., conferences, webinars)

Medical journals and publications

Colleagues or specialist consultations

Clinical decision support tools (e.g., EMR-integrated resources)

Guidelines from professional associations (e.g., Diabetes Canada, Hypertension Canada)

Pharmaceutical representative discussions

Other

Please Specify

7) Which guideline do you most often reference when making treatment decisions for your patients with diabetes? *

Diabetes Canada Clinical Practical Guidelines

American Diabetes Association (ADA) guidelines)

Local/Regional

None

8) How frequently do you refer to the guideline you selected in the previous question? *

Always

Often

Sometimes

Rarely

9) Were you aware of the recent updates to the Diabetes Canada Clinical Practice Guidelines regarding pharmacologic management of T2D? *

Yes, I am very familiar with the updates

Yes, but I have not reviewed them in detail

No, I was not aware of the updates

Not sure

10) Were you aware of the recent updates to the Diabetes Canada Clinical Practice Guidelines for the management of chronic kidney disease (CKD) in patients with T2D? *

Yes, I am very familiar with the updates

Yes, but I have not reviewed them in detail

No, I was not aware of the updates

Not sure

Section 3: Barriers to Optimal Care

1) What are the top 3 challenges you face when managing patients with T2D (SELECT TOP 3)? *

Patient non-adherence

Limited time during visits

Lack of access to allied health professionals (e.g., dietitian, diabetes educator)

Difficulty staying up to date with guidelines

Limited access to medications (e.g., cost, coverage)

Managing multimorbidity

Other

Please Specify

2) How confident are you in your knowledge of current pharmacologic treatment options for T2D, including newer agents such as GLP-1 receptor agonists and SGLT2 inhibitors? *

Not confident at all

Slightly confident

Somewhat confident

Confident

Very confident

5) what are the main challenges you face? (SELECT TOP 2)

Cost or coverage issues

Patient adherence or injection concerns

Uncertainty about guidelines or indications

Limited experience with these drug classes

Side effect or safety concerns

Other

Please Specify

5.a) What supports, education or resources would help you address these challenges? (Open-ended) *

6) How confident are you in assessing and addressing psychosocial factors such as depression or diabetes-related distress that may affect diabetes self-management? *

Not confident at all

Slightly confident

Somewhat confident

Confident

Very confident

Section 4: Education Formats

1) Which of the following educational formats do you prefer? (Check all that apply) *

In-person workshops

Virtual webinars

Online self-paced modules

Practice coaching or mentoring

Case-based discussions

Printed materials / guidelines summaries

Please specify

3) Are there any barriers that prevent you from participating in continuing education? (Selec all that apply)

Lack of time

Lack of relevant topics

Scheduling conflicts

Cost

Limited internet or technology access

Other

Please specify:

Section 5: Quality Improvement Programs in Primary Care

5.1 - Awareness and Participation

1) What is your level of involvement or awareness of QI/QA programs? *

Actively involved

Involved to a limited extent

Not involved, but aware of them

Not involved and not aware of any

If yes, which QI / QA programs have you participated in? (e.g., MyPractice, EMR supports, practice facilitation, etc.) (Open-ended)

5.2 - Attitudes Towards QI / QA

2) Please indicate your level of agreement with the following statements: (1 = Strongly Disagree, 5 = Strongly Agree)

	Minimum		Maximum
	1	2	3	4	5
QI/QA is an essential part of delivering high-quality patient care. *
I feel confident in my ability to lead or contribute to QI/QA efforts. *
QI/QA initiatives have improved patient outcomes in my practice. *
Most QI/QA programs are too time-consuming or burdensome. *
I would participate more if QI/QA activities were simpler or supported *

Please Specify

Section 5: Quality Improvement Programs in Primary Care

5.4 - Barriers and Enablers

Please specify

2) What would encourage you to participate in more QI/QA initiatives? (Select all that apply) *

Dedicated time/funding

Easy-to-use tools and templates

On-site or virtual facilitation

Peer collaboration opportunities

CME credits

Evidence of impact on patient care

Other

Please specify

5.5 Experience and Feedback

1) Describe one positive experience you’ve had with a QI/QA initiative (if any) (Open-ended)

2) Describe one challenge or negative experience you’ve had with a QI/QA initiative (if any) (Open-ended)

3) What topics or areas of care would you like to see addressed through future QI/QA efforts (Open-ended)?

5.6 - Structured Frameworks QI and QA

1) How valuable would it be to have a structured framework to support QI/QA activities in your practice? *

Not at all valuable

Slightly valuable

Moderately valuable

Very valuable

Extremely valuable

Unsure

2) Which of the following features would make a structured QI/QA framework more useful or valuable to you? (Select all that apply) *

Step-by-step guidance or templates

Access to mentorship or expert support

Integration with EMR data or tools

Examples of real-world QI projects

Tools to measure progress and outcomes

Accreditation and continuing professional development (CPD) credits

Minimal administrative burden

Peer-to-peer learning opportunities

Other

Please specify

3) What would be the most important support or feature to help you successfully participate in QI/QA activities (Open-ended)? *

	Yes	No	Not Sure
Cardiovascular risk *
Chronic kidney disease *
Diabetic retinopathy *
Neuropathy *
Depression *